These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32930811)

  • 21. Computational investigation of inhibitory mechanism of flavonoids as bovine serum albumin anti-glycation agents.
    Johari A; Moosavi-Movahedi AA; Amanlou M
    Daru; 2014 Dec; 22(1):79. PubMed ID: 25498599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin.
    Awasthi S; Murugan NA; Saraswathi NT
    Mol Pharm; 2015 Sep; 12(9):3312-22. PubMed ID: 26281017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
    Iijima K; Fujimoto D; Irie S
    Connect Tissue Res; 2007; 48(5):271-6. PubMed ID: 17882703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro evaluation of anti-methylglyoxal/glyoxal activity of three phytosterols using glycated bovine serum albumin models.
    Sobhy R; Shen Q; Abd-Elrahman AA; Khalifa I; Liang H; Li B
    Steroids; 2020 Sep; 161():108678. PubMed ID: 32565405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the functional properties of bovine serum albumin-glucose conjugates in natural deep eutectic solvents.
    Fu JJ; Sun C; Xu XB; Zhou DY; Song L; Zhu BW
    Food Chem; 2020 Oct; 328():127122. PubMed ID: 32480260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive profiling and kinetic studies of glycated lysine residues in human serum albumin.
    Shin A; Vazmitsel Y; Connolly S; Kabytaev K
    Anal Bioanal Chem; 2022 Jul; 414(17):4861-4875. PubMed ID: 35538229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins.
    Westwood ME; Thornalley PJ
    J Protein Chem; 1995 Jul; 14(5):359-72. PubMed ID: 8590604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.
    Westwood ME; McLellan AC; Thornalley PJ
    J Biol Chem; 1994 Dec; 269(51):32293-8. PubMed ID: 7798229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycation of albumin and its implication in Diabetes: A comprehensive analysis using mass spectrometry.
    Kumari N; Bandyopadhyay D; Kumar V; Venkatesh DB; Prasad S; Prakash S; Krishnaswamy PR; Balaram P; Bhat N
    Clin Chim Acta; 2021 Sep; 520():108-117. PubMed ID: 34089724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycated bovine serum albumin for use in feeding trials with animal models - In vitro methodology and characterization of a glycated substrate for modifying feed pellets.
    Nogueira Silva Lima MT; Howsam M; Delayre-Orthez C; Jacolot P; Jaisson S; Criquet J; Billamboz M; Ghinet A; Fradin C; Boulanger E; Bray F; Flament S; Rolando C; Gillery P; Niquet-Léridon C; Tessier FJ
    Food Chem; 2023 Dec; 428():136815. PubMed ID: 37450953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of glycated residue numbers on heat-induced structural changes of bovine serum albumin.
    Liu J; Xing X; Jing H
    J Sci Food Agric; 2018 Apr; 98(6):2168-2175. PubMed ID: 28960315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectroscopic and molecular modelling studies on glycation modified bovine serum albumin with cyanidin-3-O-glucoside.
    Prasanna G; Jing P
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():708-716. PubMed ID: 29982163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of glycated bovine serum albumin in microglial cells.
    Stolzing A; Widmer R; Jung T; Voss P; Grune T
    Free Radic Biol Med; 2006 Mar; 40(6):1017-27. PubMed ID: 16540397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and relative quantification of specific glycation sites in human serum albumin.
    Frolov A; Hoffmann R
    Anal Bioanal Chem; 2010 Jul; 397(6):2349-56. PubMed ID: 20496030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of cyanidin against glucose- and methylglyoxal-induced protein glycation and oxidative DNA damage.
    Suantawee T; Cheng H; Adisakwattana S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):814-821. PubMed ID: 27645922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoferulic acid, a new anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation in vitro.
    Meeprom A; Sompong W; Chan CB; Adisakwattana S
    Molecules; 2013 May; 18(6):6439-54. PubMed ID: 23722732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells.
    Chesne S; Rondeau P; Armenta S; Bourdon E
    Biochimie; 2006 Oct; 88(10):1467-77. PubMed ID: 16814919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papaverine increases human serum albumin glycation.
    Ahmadzadeh A
    J Biol Phys; 2014 Jan; 40(1):97-107. PubMed ID: 24414229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of glycation sites by tandem mass spectrometry in a synthetic lactose-bovine serum albumin conjugate, a vaccine model prepared by dialkyl squarate chemistry.
    Jahouh F; Hou SJ; Kováč P; Banoub JH
    Rapid Commun Mass Spectrom; 2012 Apr; 26(7):749-58. PubMed ID: 22368054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose and free radicals impair the antioxidant properties of serum albumin.
    Bourdon E; Loreau N; Blache D
    FASEB J; 1999 Feb; 13(2):233-44. PubMed ID: 9973311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.